Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - Cytotherapy, 2020 - Elsevier
Abstract Background Immune checkpoint inhibitors (ICIs) have revolutionized the cancer
therapeutic landscape and our perception of interactions between the immune system and …
被引用次数：10 相关文章
[PDF] academia.edu

[PDF][PDF] Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - Cytotherapy, 2020 - academia.edu
Background: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer therapeutic
landscape and our perception of interactions between the immune system and tumor cells …

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - Cytotherapy, 2020 - orbit.dtu.dk
Background: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer therapeutic
landscape and our perception of interactions between the immune system and tumor cells …

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - …, 2020 - research.regionh.dk
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer
therapeutic landscape and our perception of interactions between the immune system and …

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome.

A Borch, M Hansen, A Draghi, I Spanggaard… - …, 2020 - europepmc.org
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer
therapeutic landscape and our perception of interactions between the immune system and …

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) have revolutionized the cancer therapeutic
landscape and our perception of interactions between the immune system and tumor cells …

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - core.ku.dk
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer
therapeutic landscape and our perception of interactions between the immune system and …

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome Research output …

VAB de Lima, A Borch, M Hansen, A Draghi… - ikm.ku.dk
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer
therapeutic landscape and our perception of interactions between the immune system and …

[引用][C] Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

VAB de Lima, A Borch, M Hansen, A Draghi… - Cytotherapy, 2020 - cir.nii.ac.jp
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies
upon checkpoint inhibition: impact on clinical outcome | CiNii Research CiNii 国立情報学 …